Subtype
Female Reproductive System Neoplasm
CI-CAN-00000885Explore in graph →
Non-malignant1,630 active trials11 approved drugs139 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000885Explore in graph →
Clinical trials
7,171 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04695535 | Chemotherapy With Anlotinib in Advanced Cervical Cancer | unknown | — | 10 | Yang ShenOTHER | 1 | Jan 5, 2021 | clinicaltrials |
| NCT00501761 | Physical Activity After Endometrial Cancer | unknown | — | 326 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 31, 2020 | clinicaltrials |
| NCT04691453 |
| QM-B and QM-C Hysterectomy for Early Cervical Cancer(QMBCHECC) |
| unknown |
| N/A |
| 538 |
| Southern Medical University, ChinaOTHER |
| 1 |
| Dec 31, 2020 |
| clinicaltrials |
| NCT00454766 | Evaluating Materials to Educate Patients About Cervical Dysplasia | unknown | — | 80 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 30, 2020 | clinicaltrials |
| NCT04664244 | Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma | unknown | Phase 2 | 43 | Lei LiOTHER | 1 | Dec 22, 2020 | clinicaltrials |
| NCT04678791 | Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell Carcinoma | unknown | N/A | 286 | Peking University Third HospitalOTHER | 1 | Dec 22, 2020 | clinicaltrials |
| NCT04651738 | Cell-free DNA Methylation for Endometrial Cancer | unknown | N/A | 400 | Lei LiOTHER | 1 | Dec 21, 2020 | clinicaltrials |
| NCT04663412 | Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients With Vulvar Cancer | unknown | N/A | 2 | Azienda Ospedaliera per l'Emergenza CanizzaroOTHER | 1 | Dec 11, 2020 | clinicaltrials |
| NCT04661696 | Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer. | unknown | Phase 2 | 75 | Chinese Academy of Medical SciencesOTHER | 1 | Dec 10, 2020 | clinicaltrials |
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) | unknown | — | 1,000 | SpeciCareINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT04651933 | A Training Set for the HRD Model in EOC | unknown | — | 200 | Lei LiOTHER | 1 | Dec 4, 2020 | clinicaltrials |
| NCT04650711 | Immunohistochemical Staining of p16 for the Screening of Cervical Cancer | unknown | Phase 2 | 250 | Lei LiOTHER | 1 | Dec 3, 2020 | clinicaltrials |
| NCT04651946 | Cell-free DNA Methylation for Epithelial Ovarian Cancer | unknown | Phase 2 | 400 | Lei LiOTHER | 1 | Dec 3, 2020 | clinicaltrials |
| NCT04646954 | DNA Methylation Testing for the Screening of Uterine Cervical Lesion | unknown | Phase 3 | 12,000 | Lei LiOTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT04376073 | Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer(ANNIE) | unknown | Phase 2 | 40 | Jihong LiuOTHER | 1 | Nov 25, 2020 | clinicaltrials |
| NCT03961412 | A Family-based Intervention to Improve Pap Test Screening Among Under-screened Chinese American Immigrant Women | unknown | Early Phase 1 | 224 | University of Nevada, RenoOTHER | 0 | Nov 24, 2020 | clinicaltrials |
| NCT04635956 | Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas | unknown | Phase 2 | 20 | Lei LiOTHER | 1 | Nov 19, 2020 | clinicaltrials |
| NCT04556071 | Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer(AVANIRA3) | unknown | Phase 2 | 32 | Xiaoxiang ChenOTHER | 1 | Nov 10, 2020 | clinicaltrials |
| NCT04114968 | Offering Cervical Cancer Screening to Older Women | unknown | — | 20,000 | University of AarhusOTHER | 1 | Nov 6, 2020 | clinicaltrials |
| NCT03931083 | Screening Test Accuracy of Gynocular™, HR-HPV Testing, VIA for Detection of Cervical Neoplastic Lesions, in Women Living With HIV | unknown | — | 450 | University of BernOTHER | 1 | Nov 3, 2020 | clinicaltrials |
| NCT04566952 | Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer(ANLOLA) | unknown | Phase 2 | 68 | Xiaoxiang ChenOTHER | 1 | Oct 30, 2020 | clinicaltrials |
| NCT03628118 | A Research on Hidden Blood Loss in Open Radical Hysterectomy and Pelvic Lymphadenectomy | unknown | — | 105 | Second Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Oct 29, 2020 | clinicaltrials |
| NCT03877627 | The Clinical Significance of Sentinel Lymph Node Imaging Combined With Imaging Examination in Pelvic and Peritoneal Lymphadenectomy for Endometrial Carcinoma | unknown | N/A | 60 | Second Affiliated Hospital of Wenzhou Medical UniversityOTHER | 0 | Oct 29, 2020 | clinicaltrials |
| NCT04588090 | A Prospective Randomized Controlled Study of Radiotherapy and the Concurrent Three-week and Single-week TP Chemotherapy for Advanced Cervical Squamous Cell Carcinoma and the Correlation Between HPV Classification and Sensitivity. | unknown | N/A | 200 | Chongqing University Cancer HospitalOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT04590625 | Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer | unknown | Phase 2 | 58 | Zhongshan Hospital Xiamen UniversityOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT04584957 | Prophylactic Negative Pressure Wound Therapy (VAC) in Gynecologic Oncology (G.O.)(GO-VAC) | unknown | N/A | 196 | Catholic University of the Sacred HeartOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT02750124 | IT-system Development for Reaching Cervix Cancer Screening Non-attenders | unknown | N/A | 8,000 | Karolinska InstitutetOTHER | 0 | Oct 5, 2020 | clinicaltrials |
| NCT03899610 | A Phase II Study of Neoadjuvant Chemotherapy Plus Durvalumab (MEDI4736) and Tremelimumab in Advanced-stage Ovarian Cancer (TRU-D)(KGOG3046) | unknown | Phase 2 | 24 | Yonsei UniversityOTHER | 1 | Sep 28, 2020 | clinicaltrials |
| NCT04555473 | Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids(TAILOR) | unknown | — | 48 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Sep 18, 2020 | clinicaltrials |
| NCT01730651 | High Dose Intensity Modulated Radiation Therapy in the Cervical Cancer With Metastatic Lymphadenopathies. | unknown | N/A | 55 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 16, 2020 | clinicaltrials |
| NCT04279509 | Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE) | unknown | N/A | 35 | National University Hospital, SingaporeOTHER | 1 | Sep 9, 2020 | clinicaltrials |
| NCT04473339 | A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation | unknown | Phase 3 | 280 | CAI HongbingOTHER | 1 | Sep 9, 2020 | clinicaltrials |
| NCT04402333 | Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival(MIRRORS) | unknown | — | 40 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Sep 2, 2020 | clinicaltrials |
| NCT04528940 | Tumor Grade Determines PD-1/PDL-1 Expression | unknown | — | 100 | RWJ Barnabas Health at Jersey City Medical CenterOTHER | 1 | Aug 27, 2020 | clinicaltrials |
| NCT04520464 | Clinical Trial Comparing the Self-test for Cervicovaginal Sample Versus Samples From Service Provider (Xyto-Ro)(Xyto-Ro) | unknown | N/A | 444 | Hospital General de México Dr. Eduardo LiceagaOTHER_GOV | 1 | Aug 20, 2020 | clinicaltrials |
| NCT00652119 | Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin | unknown | Phase 1 | 46 | Massachusetts General HospitalOTHER | 1 | Aug 19, 2020 | clinicaltrials |
| NCT03295526 | Selective Pelvic Lymphadenectomy for IB-IIA Cervical Cancer | unknown | Phase 2 | 200 | Fudan UniversityOTHER | 1 | Aug 19, 2020 | clinicaltrials |
| NCT04516083 | Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation | unknown | — | 100 | RWJ Barnabas Health at Jersey City Medical CenterOTHER | 1 | Aug 18, 2020 | clinicaltrials |
| NCT04514289 | To Assess and Compare the Performance Two Approach for Sentinel Lymph Node (SNLD) Biopsy for Endometrial Cancer | unknown | — | 106 | Haseki Training and Research HospitalOTHER | 1 | Aug 14, 2020 | clinicaltrials |
| NCT04504110 | 68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings | unknown | Phase 2 | 30 | Peking Union Medical College HospitalOTHER | 1 | Aug 10, 2020 | clinicaltrials |
| NCT04503980 | αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors | unknown | Early Phase 1 | 10 | Shanghai Cell Therapy Group Co.,LtdINDUSTRY | 1 | Aug 7, 2020 | clinicaltrials |
| NCT04488991 | Nabothian Cyst Protects or Facilitates Against Cervical Cancer | unknown | — | 1,005 | Haseki Training and Research HospitalOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT04489706 | Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation | unknown | N/A | 20 | Ruijin HospitalOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT02986568 | Efficacy of the Standard Treatment and Fusion Ontogenetic Surgery for Gynecologic Cancers(FUSIONIV) | unknown | N/A | 380 | Seoul National University HospitalOTHER | 1 | Jul 24, 2020 | clinicaltrials |
| NCT04474951 | Food Supplements Based on Nettle and Peppermint to Control Signs and Symptoms Induced by Cancer Therapies(GALENO 1) | unknown | N/A | 60 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jul 17, 2020 | clinicaltrials |
| NCT04191603 | TWO DİFFERENT ELECTROSURGERY DEVICES AS MONOPOLAR HOOC AND PLASMAKINETIC BIPOLAR SPATULA EFFECTIVENESS DURING COLPOTOMY | unknown | N/A | 100 | Alkü Alanya Education and Research HospitalOTHER | 1 | Jun 23, 2020 | clinicaltrials |
| NCT04192643 | INTERVENTION WITH TRANEXAMIC ACID TO REDUCE HAEMORRHAGE DURING LAPAROSCOPIC MYOMECTOMY | unknown | N/A | 60 | Alkü Alanya Education and Research HospitalOTHER | 1 | Jun 23, 2020 | clinicaltrials |
| NCT04192812 | PREOPERATIVE GONADOTROPINE-RELEASING HORMONE AGONIST THERAPY BEFORE SURGERY FOR UTERİN FIBROIDS | unknown | N/A | 100 | Alkü Alanya Education and Research HospitalOTHER | 1 | Jun 23, 2020 | clinicaltrials |
| NCT04444193 | Durvalumab and Lenvatinib in Participants With Advanced and Recurrent Endometrial Carcinoma(Dulect2020-2) | unknown | N/A | 20 | Shanghai First Maternity and Infant HospitalOTHER | 0 | Jun 23, 2020 | clinicaltrials |
Data updated 24 days agoSource updated Jan 5, 2021source: clinicaltrials